Back

Journal of the International AIDS Society

19 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Impact of violence on HIV outcomes among female sex workers: A global systematic review and meta-analysis
2026-02-27 hiv aids 10.64898/2026.02.27.26346881
#1 (18.6%)
Show abstract

BackgroundFemale sex workers (FSW) are a key population for HIV prevention and care. Increasing evidence suggests that social and structural barriers are key drivers of HIV transmission. This global systematic review assesses whether experiencing violence is associated with worse HIV outcomes among FSW. Methods and FindingsWe searched MEDLINE, Embase, and PsycINFO databases for studies published from January 1st, 2010 to February 10th, 2025 assessing the impact of violence on HIV outcomes among...

2
Geographic variation in loss to follow-up from HIV care in Tanzania and its association with pharmacy refill adherence in routine programme data
2026-03-05 hiv aids 10.64898/2026.03.04.26347648
#1 (17.9%)
Show abstract

BackgroundSustained retention in HIV care is essential for achieving durable viral suppression and controlling the HIV epidemic. Loss to follow-up (LTFU) remains a persistent challenge in sub-Saharan Africa and shows substantial geographic variation. However, nationally representative analyses of routine monitoring data remain limited. Pharmacy refill data provide a scalable and objective approach for identifying individuals at risk of disengaging from care. We assessed the magnitude, spatial di...

3
Health and economic impact of geographically prioritized long-acting PrEP delivery in southern and eastern Africa
2026-02-26 hiv aids 10.64898/2026.02.24.26345396
#1 (17.8%)
Show abstract

BackgroundLong-acting injectable HIV pre-exposure prophylaxis (PrEP), including Lenacapavir, has the potential to accelerate HIV incidence declines in eastern and southern Africa (ESA). However, high product and delivery costs and constrained budgets necessitate efficient prioritization strategies to maximize impact and achieve cost-effectiveness. MethodsWe used district-level HIV incidence estimates published by UNAIDS to estimate the direct health and economic impact of prioritizing Lenacapav...

4
The impact of USAID and CDC funding cuts on HIV incidence and mortality in KwaZulu Natal, South Africa
2026-02-22 hiv aids 10.64898/2026.02.18.26346597
Top 0.1% (15.7%)
Show abstract

BackgroundAbrupt cessation of USAID and CDC resources to KwaZulu Natal province in South Africa, threatens the progress over decades to address HIV. MethodsWe used a previously developed validated HIV transmission model with input from the KZN Department of Health and local stakeholders to estimate impact of funding cuts on HIV incidence and mortality at 12-months and through 2030. We applied the model to estimate the impact of restoring funds on HIV incidence and mortality. ResultsHIV inciden...

5
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya
2026-03-02 hiv aids 10.64898/2026.02.26.26347230
Top 0.1% (14.3%)
Show abstract

BackgroundMaintaining viral suppression among people who inject drugs (PWID) living with HIV in sub-Saharan Africa remains critical to minimize drug resistance for dolutegravir (DTG)-based regimens. We evaluated PWID taking DTG to assess longitudinal rates of viral non-suppression and emergence of drug resistance mutations in Kenya. MethodsWe enrolled Kenyan PWID who had transitioned from an efavirenz (EFV) based regimen to tenofovir+lamivudine+DTG (TLD) [≥]6 months prior, and measured plasm...

6
The direct implementation costs of HIV pre-exposure prophylaxis in Lesotho and Zimbabwe: a costing study of PrEP choice involving oral pills, the dapivirine ring, and long-acting injectable cabotegravir to inform policy setting
2026-03-06 hiv aids 10.64898/2026.03.05.26347680
Top 0.2% (11.9%)
Show abstract

Because of its recent regulatory approval in southern and eastern Africa, CAB PrEP represents a scientific advancement with unknown implementation costs in most African countries. To our knowledge, this paper is the first study comparing PrEP costs in health facilities where clients had a choice between three PrEP methods. We collected and analyzed the direct service delivery costs for each method using the same costing approach and assumptions at three facilities in Lesotho and six facilities i...

7
Positive Running: a gender-transformative physical activity intervention to overcome intersectional barriers among adolescents with perinatally acquired HIV in India
2026-02-18 hiv aids 10.64898/2026.02.17.26346488
Top 0.3% (10.3%)
Show abstract

BackgroundAdolescents with perinatally acquired HIV in India experience a high burden of stigma and mental health distress alongside gendered social constraints that limit participation in supportive programs. While physical activity-based psychosocial interventions show promise for improving adolescent mental health, little is known about how gender norms and intersecting vulnerabilities shape engagement and outcomes among this population. This study examined gender-specific patterns of partici...

8
WHO early warning indicators of HIV drug resistance in children and adolescents living with HIV in Cameroon: a pre- and post-COVID-19 analysis
2026-02-14 hiv aids 10.64898/2026.02.10.26346049
Top 0.3% (9.8%)
Show abstract

COVID-19 disrupted global health service delivery, particularly among children and adolescents living with HIV (CALHIV), increasing the risk of poor treatment adherence. This study assessed the impact of the COVID-19 pandemic on WHO-recommended early warning indicators (EWIs) of HIV drug resistance (HIVDR) among CALHIV. We conducted a descriptive, longitudinal, retrospective study among children (0-9 years) and adolescents (10-19 years) receiving antiretroviral therapy (ART) in five health facil...

9
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya
2026-03-05 hiv aids 10.64898/2026.03.04.26347621
Top 0.3% (9.6%)
Show abstract

BackgroundIn trials, three-month weekly rifapentine and isoniazid (3HP) showed higher adherence and completion than the six-month daily isoniazid (6H) regimen for TB preventive treatment (TPT). However, programmatic outcome data remain limited. MethodologyWe evaluated the TPT cascade among people with HIV (PWH) aged >15 years newly enrolled in HIV care in western Kenya. Initiation and completion of 6H (Jan to Sept 2022) were compared to 3HP (Oct 2022-Sept 2023) using Chi-square tests. Correlate...

10
Prevalence And Factors Associated With False Negative Rapid Diagnostic HIV Tests Among Patients On Antiretroviral Therapy With A Non-Detectable Viral Load In Kampala, Uganda: A Cross-Sectional Study
2026-02-22 hiv aids 10.64898/2026.02.19.26346688
Top 0.4% (9.4%)
Show abstract

BackgroundEvidence emerging from Sub-Saharan Africa indicates that people living with HIV (PLHIV) on long-term antiretroviral therapy (ART) especially when the viral load is undetectable, may falsely test negative for HIV on rapid diagnostic tests. This study assessed the prevalence and factors associated with false negative rapid diagnostic HIV tests among Patients on antiretroviral therapy, with undetectable viral load levels at Kisenyi Health Center IV, Kampala, Uganda. MethodsBetween Octobe...

11
Trends in Healthcare Costs among People Living with HIV in Ontario, Canada, 2003-2018: Results from a Population-Based Retrospective Cohort Study
2026-02-19 hiv aids 10.64898/2026.02.18.26346556
Top 0.4% (9.4%)
Show abstract

ObjectiveTo quantify trends in annual mean healthcare costs per person living with HIV from 2003 to 2018 from a publicly funded healthcare system perspective. DesignWe conducted a retrospective population-based study using administrative health data in Ontario, Canada, including 25,842 people living with HIV diagnosed and entering care between 1992 and 2018. A nested cohort from the Ontario HIV Treatment Network Cohort Study (n=3,516) provided additional HIV-related characteristics. MethodsAnn...

12
Predictors of loss to follow-up among patients receiving antiretroviral therapy in Njombe Region, Tanzania, 2017-2021
2026-03-02 hiv aids 10.64898/2026.02.28.26347333
Top 0.4% (9.2%)
Show abstract

BackgroundLoss to follow-up (LTFU) undermines the success of antiretroviral therapy (ART) programs, especially in high HIV prevalence regions like Njombe, Tanzania. Understanding factors influencing LTFU is critical to enhance patient retention. AimTo assess the prevalence and predictors of LTFU among people living with HIV (PLHIV) receiving ART in Njombe, Tanzania, from 2017 to 2021 MethodsWe conducted a retrospective cohort study using the National Care and Treatment Clinic (CTC2) database, ...

13
The Impact of 6-Month ART Dispensing (6MMD) on Retention in Malawi's HIV Program: A Target Trial Emulation Study
2026-02-17 hiv aids 10.64898/2026.02.16.26346393
Top 0.5% (8.5%)
Show abstract

BackgroundSix multi-month dispensing (6MMD) of antiretroviral therapy (ART) for HIV treatment clients has expanded rapidly in the past decade, but its effect on individual outcomes in routine (non-trial) care is still poorly documented and based on observational programmatic data. Malawi launched 6MMD in April 2019 and scaled-up implementation in 2020. We compared retention in care for clients who received 6MMD to those who did not using a target trial emulation (TTE) approach to minimize bias. ...

14
HIV Treatment and Program Preferences Among Ryan White Clients in New York City in the Era of Long-Acting Injectable ART: A Discrete Choice Experiment
2026-02-16 hiv aids 10.64898/2026.02.13.26346257
Top 0.7% (7.2%)
Show abstract

IntroductionDespite improvements in treatment for people living with HIV (PWH), adherence remains a challenge for many. In this study we aimed to identify preferences for daily pill or long-acting injectable (LAI) antiretroviral therapy (ART) and for possible treatment package features, among PWH enrolled in Ryan White HIV/AIDS Program Part A (RWPA) Medical Case Management (MCM) programs. MethodsParticipants were recruited from six MCM programs from across the New York RWPA eligible metropolita...

15
Utilizing pharmacy refill data to predict loss to follow-up among people living with HIV in Manyara region of Tanzania
2026-02-26 hiv aids 10.64898/2026.02.24.26347034
Top 0.7% (7.2%)
Show abstract

BackgroundAchieving optimal adherence and retention in HIV care is essential for sustaining viral suppression. Pharmacy refill records offer an objective approach to assessing adherence in settings where routine viral load testing is limited. This study evaluated pharmacy refill adherence, loss to follow-up (LTFU), and their predictors among people living with HIV (PLHIV) in the Manyara region of Tanzania. MethodsWe conducted a retrospective cohort analysis of 22,650 PLHIV across five districts...

16
Determinants of HIV Testing Uptake Among Adolescent Girls and Young Women in Mainland Tanzania: A Stratified Analysis of the 2016/17 and 2022/2023 National Surveys
2026-02-16 hiv aids 10.64898/2026.02.12.26346133
Top 0.8% (7.0%)
Show abstract

BackgroundAdolescent girls and young women (AGYW) are disproportionately vulnerable to HIV. Despite expanded HIV testing services (HTS), the majority of AGYW remain unaware of their HIV status. This study aimed to assess determinants of HIV testing uptake among AGYW in mainland Tanzania before and after stratifying by age group (15-19 and 20-24 years) using data from three national surveys conducted over time. MethodologyA cross-sectional secondary data analysis was conducted using data from th...

17
Uptake of early infant diagnosis and factors associated with its timely completion among HIV exposed infants at Lira Regional Referral Hospital: a retrospective cohort study
2026-03-02 hiv aids 10.64898/2026.02.28.26347306
Top 0.8% (7.0%)
Show abstract

BackgroundHIV exposed infants (HEIs) are at a higher risk of infant mortality compared to their counterparts who are not HIV exposed. Early Infant Diagnosis (EID) is the critical first step in reducing HIV-related infant mortality through prompt identification of HIV-infected infants and subsequent initiation of antiretroviral therapy. However, there is limited information on Uptake of EID and factors associated with its timely completion among HIV exposed infants. Therefore, this study aimed at...

18
Aligning Definitions with Realities: An Interpretive Descriptive Study on the Complexities of Measuring Retention in HIV Care in the Global Context
2026-02-16 hiv aids 10.64898/2026.02.13.26345822
Top 0.8% (6.8%)
Show abstract

BackgroundRetention in HIV care is associated with higher rates of antiretroviral treatment adherence and viral suppression, as well as lower risk of AIDS-related morbidity and mortality. However, the multidimensional nature of retention complicates measurement standardization, limiting comparability and global evaluation. This study explored how HIV stakeholders define and assess retention, aiming to develop a patient-centred and conceptually robust understanding to inform research and practice...

19
Growth, infection, and humoral immunity in children who are HIV exposed and uninfected
2026-02-27 hiv aids 10.64898/2026.02.25.26347096
Top 1% (5.8%)
Show abstract

BackgroundChildren who are HIV-exposed uninfected (HEU) show greater morbidity and mortality than HIV-unexposed children (HUU). In this study we investigate sex differences in growth, infection rates and antibody response among HEU and HUU infants. MethodsThe study enrolled 107 pregnant women with HIV and 103 pregnant women without HIV with follow-up of their infants from birth to 12 months of age. Study measures assessed included growth parameters, the prevalence of children with overt disease...

20
Y-FIT Ghana: A Study Protocol for a Youth-Led Participatory Approach to Promote Youth-Friendly HIV Self-Testing, Oral and Long-Acting Injectable Pre-Exposure Prophylaxis Uptake in Ghana
2026-03-02 hiv aids 10.64898/2026.02.23.26346606
Top 1% (5.1%)
Show abstract

IntroductionDespite progress in HIV prevention, adolescents and young adults in sub-Saharan Africa remain disproportionately affected by HIV. In Ghana, youth aged 15-24 years face persistent barriers to accessing HIV prevention services, including stigma, limited awareness of prevention options, and insufficient availability of youth-friendly services. Emerging and existing prevention approaches, including HIV self-testing, oral, and long-acting injectable pre-exposure prophylaxis offer importan...